Marketing
Why Countries With High Obesity Rates Should Subsidize GLP-1s
Countries with high obesity rates are sitting on a trillion-dollar arbitrage opportunity. Subsidizing GLP-1 medications is not a healthcare expense. It is a macroeconomic investment that will lower morbidity, boost productivity, and fundamentally restructure consumer spending patterns for decades.